Hepatitis E News and Research

RSS

Hepatitis E is a viral hepatitis (liver inflammation) caused by infection with a virus called hepatitis E virus (HEV).

Nucleic acid-amplification testing has improved the safety of the nation's blood supply

State-of-the-art testing systems to screen donated blood have improved the safety of the nation's blood supply by preventing the transmission of potentially deadly viruses, according to a new study funded by the National Heart, Lung, and Blood Institute.

18 Aug 2004

Revolutionary new test for identifying people infected with tuberculosis

The test – named T SPOT-TB – is designed to replace the century old skin test for TB, which is currently given to 600,000 UK schoolchildren every year. The test comes from discoveries made over the last 10 years at the University of Oxford by Dr Aljit Lalvani and collaborators at the Nuffield Department of Medicine.

16 Aug 2004

Horrifying research into Britain's injecting drug users

Horrifying research out today in the Journal of Epidemiology and Community Health, suggest that one in 50 and one in 80 adults between the ages of 15 and 44 in London, Liverpool, and Brighton is an injecting drug user. And users are more likely to die of their habit in Brighton, finds the study.

12 Aug 2004

Survey reveals surprising insights into parental attitudes toward teenage sexual behavior

As an estimated four million American children make the transition from junior high/middle school to high school this fall, a new national survey conducted by the Society for Adolescent Medicine reveals parents' primary concerns as they ready their teenagers for the new school year.

11 Aug 2004

Dynamics between disposable and reusable segments affect expansion of disposable drapes and gowns markets

The market for disposable surgical drapes and gowns in Europe has seen steady growth in the recent past owing to the high standards of infection control enforced by the new European Union Medical Device Directive (MDD) and EU regulations.

11 Aug 2004

Liver transplantation outcomes have significantly improved for patients with hepatitis B

Since the early 1990s, therapeutic options for patients undergoing liver transplantation for hepatitis B have evolved to include HBV immune globulin (HBIG) and lamivudine.

9 Aug 2004

Significant advance in the understanding of the hepatitis C virus (HCV)

Researchers have made a significant advance in the understanding of the hepatitis C virus (HCV) by identifying new genetic factors associated with clearing the virus spontaneously without the necessity for additional treatment.

9 Aug 2004

Correlation between HCV viral load and severity of liver disease

The significance of hepatitis C virus (HCV) serum titers (HCV viral load) has been examined in several clinical situations. There is much evidence that patients with a lower viral load have better response rates to anti-viral therapy compared to those with higher levels.

9 Aug 2004

Self-recovery from Hep C infection linked to genes that suppress action of killer immune cells

In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.

5 Aug 2004

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

Metabasis Therapeutics has announced the initiation of a multi-center, multi- national Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate in chronic hepatitis B (HBV) infected patients.

3 Aug 2004

America's childhood immunization rates are at record high levels

The U. S. Department of Health and Human Services has announced that the nation's childhood immunization rates are at record high levels, including significant increases in rates of immunization for chickenpox and pneumococcal pneumonia, the two most recent additions to the childhood immunization schedule.

2 Aug 2004

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Sydney University medical researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS in the latest round of National Health and Medical Research Council program grants.

2 Aug 2004

Drug to fight virus from the herpes family in transplant patients moves forward in trials

A drug once considered for cancer chemotherapy is advancing in clinical trials to test its effectiveness in fighting a virus from the herpes family that threatens transplant patients.

29 Jul 2004

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

Feeling sick can be "all in the head" for people with inflammatory disorders or for those receiving immunotherapy, say Robert Dantzer and Keith Kelley, professors in the department of animal sciences at the University of Illinois at Urbana-Champaign.

29 Jul 2004

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

An international study with nearly 900 patients co-infected with Human Immunodeficiency Virus (HIV) and hepatitis C virus (HCV) has shown that HCV can be treated effectively and safely, without compromising the patient’s HIV therapy.

29 Jul 2004

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

A new study reveals the highest efficacy rates ever reported among patients co-infected with hepatitis C and HIV treated with pegylated interferon and ribavirin.

28 Jul 2004

British Government needs to get its act together to tackle the soaring rates of sexually transmitted infections

The Chairman of the British Medical Association, Mr James Johnson, has called on the Government to get its act together to tackle the soaring rates of sexually transmitted infections (STIs). The Health Protection Agency (HPA) figures for 2003 released today [27 July] show that STI rates are still on the increase in England, Wales and Northern Ireland.

27 Jul 2004

European scientists expect to begin human trials using pharmaceuticals grown in GM plants

The European Union has awarded €12 million to a network of scientists in 11 European countries and South Africa and the aim is to use plants to produce vaccines and treatments against major diseases including AIDS, rabies, diabetes and TB.

23 Jul 2004

Young holidaymaker's traveling overseas face serious health issues from casual sex

A paper published this week in the British Medical Journal says that young holidaymaker's traveling overseas face serious health issues from casual sex, and even goes as far as to suggest that some could be at risk of death.

23 Jul 2004

Computer modeling method for mapping the evolution of the influenza virus

A University of California scientist working at Los Alamos National Laboratory with collaborators from the University of Cambridge (England) and the World Health Organization National Influenza Center at Erasmus Medical Center, (Rotterdam, Netherlands) have developed a computer modeling method for mapping the evolution of the influenza virus.

21 Jul 2004

Hepatitis E News and Research

Further Reading

Nucleic acid-amplification testing has improved the safety of the nation's blood supply

Revolutionary new test for identifying people infected with tuberculosis

Horrifying research into Britain's injecting drug users

Survey reveals surprising insights into parental attitudes toward teenage sexual behavior

Dynamics between disposable and reusable segments affect expansion of disposable drapes and gowns markets

Liver transplantation outcomes have significantly improved for patients with hepatitis B

Significant advance in the understanding of the hepatitis C virus (HCV)

Correlation between HCV viral load and severity of liver disease

Self-recovery from Hep C infection linked to genes that suppress action of killer immune cells

Metabasis Therapeutics announces multi-center Phase 2 study to evaluate the orally administered antiviral compound remofovir mesylate

America's childhood immunization rates are at record high levels

Researchers have secured more than $19.4 million for their work on cardiovascular and liver diseases and HIV/AIDS

Drug to fight virus from the herpes family in transplant patients moves forward in trials

Molecular pathway in the brain may explain why some patients suffering from inflammatory diseases develop depression

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

British Government needs to get its act together to tackle the soaring rates of sexually transmitted infections

European scientists expect to begin human trials using pharmaceuticals grown in GM plants

Young holidaymaker's traveling overseas face serious health issues from casual sex

Computer modeling method for mapping the evolution of the influenza virus

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News